Ok had a super quick glance and while the very quick super...

Ok had a super quick glance and while the very quick super glance is in no way doing it at all any justice, wound healing in itself is a large market but a couple of things to be wary of:

1) There are other competitors around, think PNV for instance (Another Aussie Bio company that already has sales in place), and there are a few others with treatments in the pipeline.

2) No dis-respect but the total wound market is estimated to be around the $20 Billion USD mark ⁰. Not to be sneezed at all, whatsoever, that's quite large...

HOWEVER...Par's OA market is approx $11 Billion USD...hey Mozz, thats less....yes it is but we will have it almost exclusively at least for some window AND it is the first potential DMOAD and the whole safety and durability aspect, that will increase the potential.....ALSO..you are forgetting one other thing....OA isn't the only thing we may target one day...

PAIN...Pain is estimated to be some $71 Billion in 2019 ¹...Im not at all saying that we can address all of it one day...but a fraction would be highly lucrative...


If that isn't enough, what about inflammation...?

You will fall over when I tell you how much that's worth...ready?


$91 Billion in 2019...but by 2027 that are saying $191 Billion. ²

There might be an overlap but you can easily see the size of runway we may just have one day...

I think PAR's potential wins hands down.





DYOR


ps: The OA Therapeutics market is around $11 B, but the TKA and TH etc/Surgery options is a lot more, we will surely address a % of that, thats upwards of $128 B total cost.


Ref's

0) https://www.grandviewresearch.com/industry-analysis/wound-care-market
1) https://www.alliedmarketresearch.com/pain-management-therapeutics-market
2) https://www.fortunebusinessinsights.com/anti-inflammatory-drugs-market-102825